Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Altimmune
ALT
$327M
| $41M | 0.02% |
3,213,900
+149,620
| +5% | +$1.91M |
|
602
Halozyme
HALO
$8.87B
| $40.9M | 0.02% |
1,035,523
+20,727
| +2% | +$820K |
|
603
US Foods
USFD
$17.6B
| $40.9M | 0.02% |
1,548,217
-135,951
| -8% | -$3.59M |
|
604
Home BancShares
HOMB
$5.84B
| $40.9M | 0.02% |
1,815,705
+128,126
| +8% | +$2.88M |
|
605
Evolent Health
EVH
$1.12B
| $40.8M | 0.02% |
1,136,785
+100,206
| +10% | +$3.6M |
|
606
e.l.f. Beauty
ELF
$7.83B
| $40.8M | 0.02% |
1,085,545
-357,063
| -25% | -$13.4M |
|
607
Merit Medical Systems
MMSI
$5.47B
| $40.7M | 0.02% |
720,438
+23,234
| +3% | +$1.31M |
|
608
Best Buy
BBY
$16.3B
| $40.7M | 0.02% |
641,817
-45,369
| -7% | -$2.87M |
|
609
Qualys
QLYS
$4.88B
| $40.4M | 0.02% |
289,518
+24,544
| +9% | +$3.42M |
|
610
Coca-Cola Europacific Partners
CCEP
$41.6B
| $40.2M | 0.02% |
944,259
+48,070
| +5% | +$2.05M |
|
611
Radian Group
RDN
$4.77B
| $40.2M | 0.02% |
2,085,031
-445,317
| -18% | -$8.59M |
|
612
Avnet
AVT
$4.45B
| $40.2M | 0.02% |
1,112,892
+39,871
| +4% | +$1.44M |
|
|
GBT
613
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $40.1M | 0.02% |
589,525
-60,744
| -9% | -$4.14M |
|
614
BILL Holdings
BILL
$5.17B
| $40.1M | 0.02% |
303,034
+14,843
| +5% | +$1.96M |
|
615
iShares MSCI Canada ETF
EWC
$3.24B
| $40M | 0.02% |
1,299,289
+230,108
| +22% | +$7.08M |
|
616
Builders FirstSource
BLDR
$15.5B
| $39.9M | 0.02% |
677,453
-39,113
| -5% | -$2.3M |
|
617
Corpay
CPAY
$22B
| $39.9M | 0.02% |
226,501
-13,215
| -6% | -$2.33M |
|
618
Revvity
RVTY
$10B
| $39.9M | 0.02% |
331,501
-9,894
| -3% | -$1.19M |
|
619
Royalty Pharma
RPRX
$15.5B
| $39.8M | 0.02% |
990,138
+9,590
| +1% | +$385K |
|
620
Clearway Energy Class C
CWEN
$3.34B
| $39.6M | 0.02% |
1,243,844
+168,660
| +16% | +$5.37M |
|
621
Hancock Whitney
HWC
$5.33B
| $39.5M | 0.02% |
861,287
+130,571
| +18% | +$5.98M |
|
622
Jacobs Solutions
J
$17.3B
| $39.4M | 0.02% |
439,571
-11,704
| -3% | -$1.05M |
|
623
Kilroy Realty
KRC
$5.05B
| $39.4M | 0.02% |
935,835
-110,883
| -11% | -$4.67M |
|
624
Iridium Communications
IRDM
$2.27B
| $39.4M | 0.02% |
887,852
+44,343
| +5% | +$1.97M |
|
625
Cincinnati Financial
CINF
$24B
| $39.3M | 0.02% |
438,336
-11,838
| -3% | -$1.06M |
|